These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36103980)

  • 1. Obesity and contraceptive use: impact on cardiovascular risk.
    Rosano GMC; Rodriguez-Martinez MA; Spoletini I; Regidor PA
    ESC Heart Fail; 2022 Dec; 9(6):3761-3767. PubMed ID: 36103980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
    Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
    Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WHO scientific group meeting on cardiovascular disease and steroid hormone contraceptives.
    Wkly Epidemiol Rec; 1997 Nov; 72(48):361-3. PubMed ID: 9409187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
    Horton LG; Simmons KB; Curtis KM
    Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined hormonal contraception and venous thromboembolism.
    Martínez F; Avecilla A
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31711271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of hormonal contraception for obese women.
    Rocha ALL; Campos RR; Miranda MMS; Raspante LBP; Carneiro MM; Vieira CS; Reis FM
    Expert Opin Drug Saf; 2017 Dec; 16(12):1387-1393. PubMed ID: 28988524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined hormonal contraceptive use among breastfeeding women: an updated systematic review.
    Tepper NK; Phillips SJ; Kapp N; Gaffield ME; Curtis KM
    Contraception; 2016 Sep; 94(3):262-74. PubMed ID: 26002804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contraception in women with obesity].
    Ciangura C; Bachelot A
    Med Sci (Paris); 2021 Oct; 37(10):882-887. PubMed ID: 34647876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic diseases in young women and the influence of oral contraceptives.
    Lidegaard O
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S62-7. PubMed ID: 9753312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006133. PubMed ID: 24788670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contraception and obesity].
    Lobert M; Pigeyre M; Gronier H; Catteau-Jonard S; Robin G
    Gynecol Obstet Fertil; 2015 Nov; 43(11):740-7. PubMed ID: 26527416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
    Lopez LM; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006133. PubMed ID: 22513937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
    Dragoman M; Curtis KM; Gaffield ME
    Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal contraceptives for contraception in overweight or obese women.
    Lopez LM; Bernholc A; Chen M; Grey TW; Otterness C; Westhoff C; Edelman A; Helmerhorst FM
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008452. PubMed ID: 27537097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined oral contraceptives: risks and benefits.
    Thorogood M; Villard-Mackintosh L
    Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal contraceptive use in Ireland: trends and co-prescribing practices.
    O'Mahony L; Liddy AM; Barry M; Bennett K
    Br J Clin Pharmacol; 2015 Dec; 80(6):1315-23. PubMed ID: 26503402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology.
    Gourdy P; Bachelot A; Catteau-Jonard S; Chabbert-Buffet N; Christin-Maître S; Conard J; Fredenrich A; Gompel A; Lamiche-Lorenzini F; Moreau C; Plu-Bureau G; Vambergue A; Vergès B; Kerlan V
    Ann Endocrinol (Paris); 2012 Nov; 73(5):469-87. PubMed ID: 23078975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.